Quantitative clinical assessment of chronic anterior myocardial infarction with delayed enhancement magnetic resonance imaging and QRS scoring - 28/08/11
, Randy M Setser, DSc c, Ronald H Selvester, MD d, Therese Billgren a, Jane M Kasper, RN, BSN c, Charles Maynard, PhD e, Olle Pahlm, MD, PhD a, Håkan Arheden, MD, PhD a, Richard D White, MD, FACC cAbstract |
Background |
Both the regional and global myocardial extent of chronic myocardial infarction (MI) are important prognostic factors for length and quality of life and also crucial for the choice of therapy in patients with ischemic heart disease. Our aim was to develop and validate techniques for comparison between regional and global size of remote anterior MI in the left ventricle quantified with both magnetic resonance imaging (MRI) and electrocardiogram (ECG).
Methods |
Delayed-enhancement (DE) MRI was used as a clinical “gold standard” for MI size to evaluate the extent of MI estimated with the commonly available standard 12-lead ECG. A method for comparing global and regional quantifications of MI with DE-MRI and ECG was developed. The Selvester QRS-scoring system was used for estimating MI size electrocardiographically.
Results |
Twenty-five patients with chronic single anterior MI, documented with DE-MRI, were studied. The best agreement for mean % MI per regional segment of the left ventricle was found in the middle third (26% vs 27%), whereas the most significant discrepancy was found in the apex (56% vs 30%). The global MI size of the left ventricle averaged 21 ± 9% with DE-MRI and 22% ± 12% with ECG, with a correlation of r = 0.40 (P <.05).
Conclusions |
The current Selvester QRS scoring system performs well for quantifying anterior MI in the mid-regions of the left ventricle. The diagnostic performance of the Selvester QRS-scoring system for quantifying MI in the other regions, particularly the left ventricular apex, can potentially be improved, with DE-MRI as the gold standard.
Le texte complet de cet article est disponible en PDF.Plan
 | Suppported by Inovise Medical, Inc, Newberg, Ore. Guest Editor for this manuscript was Thomas H. Marwick, MB, BS, PhD, Princess Alexandra Hospital, Brisbane, Australia. |
Vol 146 - N° 2
P. 359-366 - août 2003 Retour au numéro
Article précédent
- Effect of fasting glucose levels on mortality rate in patients with and without diabetes mellitus and coronary artery disease undergoing percutaneous coronary intervention
- Joseph B Muhlestein, Jeffrey L Anderson, Benjamin D Horne, Farangis Lavasani, Chloe A Allen Maycock, Tami L Bair, Robert R Pearson, John F Carlquist, Intermountain Heart Collaborative Study (IHCS) Group
- Pioglitazone reduces neointimal tissue proliferation after coronary stent implantation in patients with type 2 diabetes mellitus: an intravascular ultrasound scanning study
- Tsutomu Takagi, Atsushi Yamamuro, Koichi Tamita, Kenji Yamabe, Minako Katayama, Shin Mizoguchi, Motoaki Ibuki, Tomoko Tani, Kazuaki Tanabe, Kunihiko Nagai, Kenichi Shiratori, Shigefumi Morioka, Junichi Yoshikawa
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?